MO logo
MO

Altria Group Inc

Tobacco

Altria Group Inc (MO) Stock News

The latest MO headlines and market coverage — 30 recent stories, updated throughout the day.

  • GlobeNewswire Inc.·

    VERRA MOBILITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Verra Mobility Corporation on Behalf of Verra Mobility Stockholders and Encourages Investors to Contact the Firm

    Law firm Bragar Eagel & Squire is investigating Verra Mobility Corporation after the company announced on May 26, 2026 that Avis Budget Group terminated its contract effective September 2026. The termination is expected to reduce Verra Mobility's 2026 annualized revenue by $135-145 million and segment profit by $120-125 million, causing the stock price to decline. The firm is seeking stockholders who suffered losses to discuss potential securities law violations.

  • Benzinga·

    BMO Announces Changes to its Mutual Fund Product Line-Up

    BMO Investments Inc. announced several changes to its mutual fund offerings, including renaming BMO International Equity Fund to BMO Market+ International Equity Fund, qualifying new ETF series securities for distribution across multiple funds, and changing ticker symbols for six Active ETF Series funds effective June 24, 2026.

  • Benzinga·Neutral

    JOHN HANCOCK CLOSED-END FUNDS DECLARE MONTHLY DISTRIBUTIONS

    John Hancock Investment Management announced monthly distributions for its closed-end funds on June 1, 2026. The Tax-Advantaged Dividend Income Fund (HTD) will distribute $0.1580 per share monthly, while the Premium Dividend Fund (PDT) will distribute $0.0825 per share monthly. All distributions are scheduled for payment on June 30, 2026.

  • Benzinga·

    DR. PHONE FIX REPORTS RECORD Q1 2026 RESULTS AND CONTINUED NATIONAL EXPANSION MOMENTUM

    Q1 Revenue Up 44% YoY; Same-Store Sales Up 29%; Adjusted EBITDA Turns Positive as Company Advances National Expansion Strategy EDMONTON, AB , June 1, 2026 /CNW/ - Dr. Phone Fix Canada Corporation (TSXV: DPF) ("Dr. Phone Fix" or the "Company"), one of Canada's fastest-growing and award-winning consumer electronics repair and resale platforms, today reported financial results for the three months ended March 31, 2026, and provided an update on recent corporate developments. The Company operates a network of 44 corporately owned stores across five Canadian provinces. Financial Results Summary (CAD) (all dollar amounts in 000's) Three Months Ended Mar 31, 2026 Three Months Ended Mar 31, 2025 Variance (%) Revenue 3,162 2,196 +44 % Gross Profit 1,621 1,210 +34 % Gross Margin 51.3 % 55.1 % -3.8 pp Operating Expenses (SG&A) 2,476 1,754 +41 % Adjusted EBITDA(1) 88 (13) n/m Cash 291 1,558 -81 % (1) See Non-GAAP Financial Measure towards the end of this document. "Q1 reflected continued progress in the execution of our strategy with revenue increasing 44% year-over-year and comparable-store sales increasing 29%, even in what is typically our seasonally weakest quarter," said Piyush Sawhney, Founder and Chief Executive Officer of Dr. Phone Fix. "We also delivered positive Adjusted EBITDA, generated positive operating cash flow, and continued to improve execution across our national network while integrating recently acquired locations and advancing our OEM, insurance, supplier, repair and certified pre-owned device programs." Mr. Sawhney continued, "We have spent the past year building the foundation for a national, carrier-neutral device lifecycle platform. Today, we have 44 corporately owned locations across five provinces, a growing pipeline of acquisition and greenfield opportunities, and a strategy focused on disciplined expansion and stronger unit-level economics throug

  • GlobeNewswire Inc.·

    NUAI DEADLINE MONDAY: ROSEN, NATIONAL TRIAL LAWYERS, Encourages New Era Energy & Digital, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 1 Deadline in Securities Class Action – NUAI

    Rosen Law Firm reminds investors in New Era Energy & Digital, Inc. (NUAI) who purchased securities between November 6, 2024 and December 29, 2025 of the June 1, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges the company made false statements about its Texas Critical Data Centers project and was involved in a fraudulent scheme regarding oil and gas wells in New Mexico, resulting in misleading financial results.

  • GlobeNewswire Inc.·

    Íslensk þýðing á fyrri tilkynningu; Oculis tilkynnir um helstu niðurstöður úr fasa 3 DIAMOND rannsóknunum á OCS-01 við sjónhimnubjúg af völdum sykursýki

    Oculis announced that its OCS-01 eye drops failed to meet the primary endpoint of improving visual acuity in two Phase 3 trials for diabetic macular edema (DME), though secondary endpoints showed significant retinal thickness reduction. The company will not pursue FDA approval for OCS-01 for DME and will redirect resources toward its PIONEER trial for Privosegtor and PREDICT-1 trial for Licaminlimab.

  • GlobeNewswire Inc.·

    Oculis Announces Topline Results from DIAMOND Phase 3 Trials with OCS-01 in Diabetic Macular Edema

    Oculis announced that its Phase 3 DIAMOND-1 and DIAMOND-2 trials of OCS-01 eye drops failed to meet the primary endpoint of improved best corrected visual acuity (BCVA) in diabetic macular edema patients at week 52, despite showing substantial retinal thickness reduction. The company will not pursue FDA filing for OCS-01 in DME and will redirect resources to its Privosegtor and Licaminlimab programs. Oculis maintains a strong financial position with $278 million in cash runway into 2H 2029.

  • GlobeNewswire Inc.·

    GOSSAMER BIO DEADLINE MONDAY JUNE 1st: Bragar Eagel & Squire, P.C. Urges Gossamer Bio, Inc. (NASDAQ:GOSS) Investors with Large Losses to Contact the Firm Before Monday June 1st

    A class action lawsuit has been filed against Gossamer Bio, Inc. (NASDAQ: GOSS) for allegedly providing materially false and misleading statements regarding its Phase 3 PROSERA study for pulmonary arterial hypertension treatment. The company is accused of expressing confidence in the trial design while concealing adverse facts about placebo response controls at Latin American testing sites, causing investors to purchase securities at artificially inflated prices. Investors who purchased shares between June 16, 2025, and February 20, 2026, have until June 1, 2026, to apply as lead plaintiff.

  • GlobeNewswire Inc.·

    NEW ERA ENERGY (NASDAQ:NUAI) DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Reminds New Era Energy & Digital, Inc. Investors of the June 1st Deadline to Seek Lead Plaintiff Role

    A class action lawsuit has been filed against New Era Energy & Digital, Inc. (NASDAQ: NUAI) for allegedly making false statements about its Texas Critical Data Centers project and engaging in a fraudulent scheme involving oil and gas wells in New Mexico. Investors who purchased securities between November 6, 2024 and December 29, 2025 can seek lead plaintiff status by June 1, 2026.

  • GlobeNewswire Inc.·

    PINTEREST CLASS ACTION DEADLINE TOMORROW: Pinterest, Inc. Investors Have Until May 29th to Contact Bragar Eagel & Squire, P.C. to Seek Lead Plaintiff Role

    A class action lawsuit has been filed against Pinterest, Inc. for allegedly making false and misleading statements about reduced advertising revenues, overstated ability to manage U.S. tariff impacts, and an imminent restructuring. Investors who purchased Pinterest securities between February 7, 2025 and February 12, 2026 have until May 29, 2026 to apply as lead plaintiff.

  • Benzinga·Neutral

    ARMOUR Residential REIT, Inc. Announces June 2026 Dividend Rate per Common Share

    ARMOUR Residential REIT announced its June 2026 cash dividend of $0.24 per common share, with a record date of June 15, 2026 and payment date of June 29, 2026. The company, which invests in residential mortgage-backed securities issued or guaranteed by U.S. Government-sponsored enterprises, maintains its REIT status by distributing substantially all ordinary taxable income to shareholders.

  • Benzinga·

    REPORT ON FINANCIAL RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2026

    TORONTO , May 28, 2026 /CNW/ - Mitchell Cohen, Chief Executive Officer and President of Urbanfund Corp. (TSXV: UFC ) ("Urbanfund" or the "Company"), confirmed today that the Company has filed its financial statements for the three months ended March 31, 2026 (the "Consolidated Financial Statements") and corresponding Management's Discussion and Analysis ("MD&A"). BUSINESS OVERVIEW AND STRATEGY Business Overview Urbanfund Corp. is an incorporated entity listed on the TSX Venture Exchange ("TSX-V") under the symbol UFC. The Company is a reporting issuer in Alberta, British Columbia and Ontario. Urbanfund's focus is to invest in Canadian real estate and real estate related projects with a focus on a mix of both residential and commercial properties. The Company's assets are located in Toronto, Brampton, Belleville, Kitchener and London, Ontario, Quebec City and Montreal, Quebec and Dartmouth, Nova Scotia. Operational Highlights Part of Urbanfund's strength is its ability to attract partners with proven track records with both residential and commercial development expertise. Urbanfund continues to build alliances with its strategic partners: 1040 Martin Grove Road, Toronto – During the three months ended March 31, 2026, two commercial units were sold for sales proceeds of $778,732 (March 31, 2025, two commercial units for $841,776). To date, the Company's capital contribution of $1,870,000 has been fully returned, and an additional profit distribution of $822,545 has been received to date, of which $154,000 was received subsequent to the quarter end. 270-330 Esna Park Drive, Markham - During the three months ended March 31, 2026, four commercial units were sold for sales proceeds of $901,952 (March 31, 2025 – four commercial units for $691,991). To date, the company has received $1,462,521 of distribution, of which $382,427 was received subsequent to the quarter end.

  • Reuters·Neutral

    US-Iran MOU on 60-day ceasefire extension reached, but Trump must approve, source says - Reuters

    US-Iran MOU on 60-day ceasefire extension reached, but Trump must approve, source says  Reuters

  • Benzinga·

    MERGER BETWEEN RICHMOND MUTUAL BANCORPORATION, INC. AND THE FARMERS BANCORP, FRANKFORT, INDIANA RECEIVES SHAREHOLDER APPROVAL

    Richmond Mutual Bancorporation, Inc. and The Farmers Bancorp have received necessary shareholder approvals for their planned merger. Farmers Bancorp shareholders will receive 3.40 shares of Richmond Mutual common stock for each share owned. The transaction is expected to close by end of Q2 2026. The combined company will operate as Richmond Mutual Bancorporation, Inc. on Nasdaq under ticker RMBI, with the bank operating as First Bank Midwest.

  • Benzinga·

    BMO Financial Group Increases Common Share Dividend by 4 cents from the prior quarter, up 5 percent from the prior year

    Bank of Montreal's Board of Directors declared a quarterly dividend of $1.71 per common share, representing a 4 cent (2%) increase from the prior quarter and a 5% increase year-over-year. The dividend is payable on August 26, 2026, to shareholders of record on July 30, 2026. Shareholders can participate in a dividend reinvestment plan to purchase additional shares on the open market.

  • Benzinga·

    BMO Financial Group Reports Second Quarter 2026 Results

    BMO's Second Quarter 2026 Report to Shareholders, including the unaudited interim consolidated financial statements for the period ended April 30, 2026, are available online at www.bmo.com/investorrelations , on the Canadian Securities Administrators' website at www.sedarplus.ca , and on the EDGAR section of the U.S. Securities and Exchange Commission's website at www.sec.gov . Financial Results Highlights Second Quarter 2026 compared with Second Quarter 2025: Reported net income 1 of $2,630 million, an increase of 34% from $1,962 million; adjusted net income 1 of $2,733 million, an increase of 34% from $2,046 million Reported earnings per share (EPS) 2 of $3.53, an increase of 41% from $2.50; adjusted EPS 1, 2 of $3.67, an increase of 40% from $2.62 Provision for credit losses (PCL) of $739 million, a decrease from $1,054 million Reported return on equity (ROE) of 13.0%, compared with 9.4%; adjusted ROE 1 of 13.5%, compared with 9.8% Common Equity Tier 1 (CET1) Ratio 3 of 13.0%, compared with 13.5% Declared a quarterly dividend of $1.71 per common share, an increase of $0.08 or 5% from the prior year and $0.04 or 2% from the prior quarter Year-to-Date 2026 compared with Year-to-Date 2025: Reported net income 1 of $5,119 million, an increase of 25% from $4,100 million; adjusted net income 1 of $5,284 million, an increase of 22% from $4,335 million Reported EPS 2 of $6.92, an increase of 30% from $5.34; adjusted EPS 1, 2 of $7.15, an increase of 26% from $5.66 PCL of $1,485 million, a decrease from $2,065 million Reported ROE of 12.5%, compared with 10.0%; adjusted ROE 1 of 12.9%, compared with 10.6% TORONTO , May 27, 2026 /CNW/ - BMO Financial Group (TSX: BMO ) (NYSE: BMO ) reported net income for the second quarter ended April 30, 2026 was $2,630 million, compared with $1,962 million in the prior year, and EPS of $3.53, compared with $2.50. Reported ROE was 13.0%, co

  • GlobeNewswire Inc.·

    IBRX DEADLINE TOMORROW: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ImmunityBio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 26 Deadline in Securities Class Action First Filed by the Firm - IBRX

    Rosen Law Firm reminds ImmunityBio investors of the May 26, 2026 lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that defendants made false and misleading statements about Anktiva's capabilities and ImmunityBio's business operations. Investors who purchased securities between January 19, 2026 and March 24, 2026 may be entitled to compensation.

  • Benzinga·

    RICHMOND MUTUAL BANCORPORATION, INC. ANNOUNCES QUARTERLY DIVIDEND

    Richmond Mutual Bancorporation, Inc. (NASDAQ: RMBI) announced that its Board of Directors has declared a quarterly cash dividend of $0.15 per share, payable on June 17, 2026, to stockholders of record as of June 3, 2026.

  • Benzinga·

    BRAEMAR HOTELS & RESORTS DECLARES MONTHLY PREFERRED DIVIDENDS FOR MAY 2026

    Braemar Hotels & Resorts Inc. (NYSE: BHR) announced the declaration of monthly preferred dividends across multiple series of preferred stock. The company declared partial cash dividends for Series D, E, and M Redeemable Preferred Stock, with payments scheduled for June and July 2026. As of April 30, 2026, the company had 11.1 million shares of Series E and 1.4 million shares of Series M preferred stock outstanding.

  • GlobeNewswire Inc.·

    FLYTE ACTIVATES HIGH-FREQUENCY MEMORIAL DAY WEEKEND FLIGHT NETWORK TO CAPTURE SURGING NORTHEAST DEMAND

    Flyte, a regional air mobility company, announced full-scale activation of its Memorial Day flight network across the Northeast corridor, deploying aircraft on high-frequency short-haul routes including NYC to Nantucket, Hamptons, and Martha's Vineyard. The company aims to capture premium travel demand during the holiday weekend surge by offering sub-one-hour flights as an alternative to congested ground travel.

  • GlobeNewswire Inc.·Neutral

    FIVE IRON GOLF RETURNS WITH ITS ANNUAL WOMEN’S GOLF MONTH PROGRAM, PRESENTED WITH GOLF DIGEST

    Five Iron Golf launched its third annual Women's Golf Month campaign throughout June 2026 in partnership with Golf Digest, offering free golf on Wednesdays, $5 first-month memberships, and women-focused social events across participating locations. The initiative aims to make golf more accessible and welcoming to women, building on momentum from previous years where thousands of women joined lessons, leagues, and memberships.

  • GlobeNewswire Inc.·

    YourUpdateTV speaks with Meaghan B. Murphy: MEMORIAL DAY MADE EASY: FRESH FLAVORS, FEEL-GOOD ESSENTIALS & EFFORTLESS SUMMER LIVING

    Lifestyle expert Meaghan B. Murphy shares Memorial Day entertaining tips featuring Wendy's upgraded Spicy Chicken Sandwich with enhanced marinade and crispy panko breading, and Genova Premium Tuna for a Mediterranean-inspired salad. The recommendations highlight convenient, quality food options as Americans prepare for summer gatherings and cookouts.

  • Benzinga·

    BMO Announces Cash Distributions for Certain BMO ETFs and ETF Series of BMO Mutual Funds for May 2026

    BMO Asset Management Inc. and BMO Investments Inc. announced May 2026 cash distributions for BMO ETFs and ETF Series unitholders. The ex-dividend and record date is May 28, 2026, with distributions payable on June 2, 2026. The announcement includes distribution amounts for over 100 BMO ETFs and ETF Series across various asset classes including bonds, equities, and covered call strategies.

  • GlobeNewswire Inc.·

    POWER SOLUTIONS DEADLINE TOMORROW MAY 19th: Bragar Eagel & Squire, P.C. Reminds Power Solutions International, Inc. Investors to Contact the Firm Before May 19th Regarding Their Rights

    A class action lawsuit has been filed against Power Solutions International, Inc. (NASDAQ: PSIX) for allegedly making false and misleading statements about its ability to capture sales demand in the data center market and understating manufacturing capacity enhancement costs. Investors who purchased securities between May 8, 2025 and March 2, 2026 have until May 19, 2026 to apply as lead plaintiff.

  • Benzinga·

    NATURE'S MIRACLE HOLDING INC. ANNOUNCES STRATEGIC MOU WITH DROMNI INTELLIGENCE TO DEVELOP AI-POWERED AUTONOMOUS ROBOTICS SOLUTIONS FOR U.S. AGRICULTURE, ENERGY AND DATA CENTER MARKETS

    Nature's Miracle Holding Inc. has entered into a Memorandum of Understanding with DROMNI Intelligence Technology Ltd. to collaborate on developing and commercializing AI-enabled autonomous robotics solutions for the U.S. agriculture, energy, and data center markets. The partnership will focus on unmanned ground vehicle deployment, smart infrastructure automation, and pilot programs across greenhouse operations, logistics, energy infrastructure, and industrial automation.

  • GlobeNewswire Inc.·

    NANOBIOTIX ANNONCE LA PRÉSENTATION DE DONNÉES DE LA PREMIÉRE PARTIE DE L’ÉTUDE CLINIQUE RANDOMISÉE DE PHASE 2 EVALUANT JNJ-1900 (NBTXR3) DANS LES CANCERS DU POUMON DE STADE 3 INOPÉRABLE

    Nanobiotix announced early results from the Phase 2 CONVERGE study evaluating JNJ-1900 (NBTXR3), a nanoradioenhancer developed in collaboration with Johnson & Johnson, in patients with stage 3 inoperable non-small cell lung cancer. The study showed promising efficacy with an 85.7% overall response rate and 57.1% complete response rate in 7 patients who completed treatment, compared to less than 5% complete response rates with current standard of care.

  • Benzinga·

    KEYCORP DECLARES QUARTERLY CASH DIVIDEND ON COMMON SHARES AND PREFERRED STOCKS AND ANNOUNCES NEW SHARE REPURCHASE PROGRAM

    KeyCorp announced a quarterly cash dividend of $0.205 per share on common stock payable June 15, 2026, along with dividends on multiple preferred stock series. The company also authorized a new $3.0 billion share repurchase program, replacing its previous $1.0 billion authorization with approximately $280 million remaining.

  • Benzinga·

    PENSKE AUTOMOTIVE GROUP ANNOUNCES 22ND QUARTERLY DIVIDEND INCREASE

    Penske Automotive Group (NYSE: PAG) announced its 22nd consecutive quarterly dividend increase, raising the quarterly dividend to $1.42 per share, up $0.02 or approximately 1.4%. The dividend is payable June 3, 2026. The company's President Robert H. Kurnick, Jr. stated the increase reflects the company's balanced approach to capital allocation including dividends, share repurchases, and strategic acquisitions.

  • GlobeNewswire Inc.·

    Silexion Therapeutics Announces Initiation of GMP Clinical Supply Manufacturing of SIL204 with Leading Global CDMO, and New Approval of Phase 2/3 Trial From Tel Aviv Sourasky Medical Center

    Silexion Therapeutics has initiated GMP clinical manufacturing of SIL204, its next-generation siRNA therapy targeting mutated KRAS in pancreatic cancer, in collaboration with CDMO Catalent at its Limoges, France facility. The company received approval from Tel Aviv Sourasky Medical Center's Helsinki Ethics Committee for its planned Phase 2/3 trial in locally advanced pancreatic cancer, following earlier approvals from the Israeli Ministry of Health and a clinical trial application submission to Germany's BfArM.

  • GlobeNewswire Inc.·

    Mowi ASA (OSE: MOWI): Notice of Annual General Meeting 3 June 2026

    Mowi ASA has scheduled its Annual General Meeting for June 3, 2026, as a digital meeting. The company's Board has also resolved to distribute a quarterly dividend of NOK 2.30 per share to shareholders.

Showing 10 of 30 MO stories

Including: "VERRA MOBILITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Verra Mobility Corporation on Behalf of Verra Mobility Stockholders and Encourages Investors to Contact the Firm"

Sign up free to see all 30 + get insider-buy alerts.

Sign up free →